These HIV Phase II trials have been designed in coordination with BP & Board of experts in the HIV field to obtain the data required. Any negotiations will be a continuation from extensive talks from prior results. Covid will be key to demonstrating broad spectrum direct acting antiviral activity in humans and may put a spanner in the works when it comes to prior extensive negotiations.
Also please name a Biotech on ASX who entitled to and not claiming R&D tax offset?
BIT Price at posting:
7.9¢ Sentiment: Buy Disclosure: Held
